A study researched the relationship between TILs with response to neoadjuvant chemotherapy in breast cancer and reported that the pathologic complete response (pCR) rate was positively relevant to TILs in human HER2-positive and TNBC samples (12). This evidence concerns the gene ERBB2 and breast carcinoma.